Ensysce Biosciences
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7946 Ivanhoe Ave Ste 201, La Jolla, Cali...Phone Number
(858) 263-4196Website
www.ensysce.comRevenue
<$5 MillionStock Symbol
ENSCIndustry
About Ensysce Biosciences
Ensysce Biosciences is a clinical-stage biotechnology company focused on developing innovative oral drug delivery technologies designed to improve the safety of prescription medications, particularly in the treatment of severe and chronic pain. The companys proprietary platforms aim to reduce risks of drug abuse, misuse, and overdose by using advanced chemistry-based mechanisms that control how active drug ingredients are released and activated in the body. Its research and development efforts are centered on creating safer opioid and non-opioid therapies, supported by collaborations with research institutions and industry partners.Explore more
SIC Code 87,873NAICS Code 54,541Ticker NASDAQ: ENSCShow moreEnsysce Biosciences Org Chart
Compare Similar Companies to Ensysce Biosciences
Compare insights from companies similar to Ensysce Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$11.5M
51-200
Private
-
1990
ML
Marlene LeuenbergerVice President and General Manager, Quotient Sciences - Philadelphia
Ensysce Biosciences Tech Stack
A closer look at the technologies used by Ensysce Biosciences
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Ensysce Biosciences
Sign Up For FreeTo access detailed company insights
Ensysce Biosciences is a clinical-stage biotechnology company focused on developing innovative oral drug delivery technologies designed to improve the safety of prescription medications, particularly in the treatment of severe and chronic pain. The companys proprietary platforms aim to reduce risks of drug abuse, misuse, and overdose by using advan... Read More
